VRDN - Viridian Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

VRDN is currently covered by 12 analysts with an average price target of $43.36. This is a potential upside of $17.65 (68.65%) from yesterday's end of day stock price of $25.71.

Viridian Therapeutics's activity chart (see below) currently has 11 price targets and 73 ratings on display. The stock rating distribution of VRDN is 96.83% BUY and 3.17% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 13.61% with an average time for these price targets to be met of 124.31 days.

Highest price target for VRDN is $44, Lowest price target is $20, average price target is $43.36.

Most recent stock forecast was given by SERGE BELANGER from NEEDHAM on 28-Oct-2024. First documented stock forecast 20-Jan-2021.

Currently out of the existing stock ratings of VRDN, 61 are a BUY (96.83%), 2 are a HOLD (3.17%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$38

$12.79 (50.73%)

$38

15 days ago
(28-Oct-2024)

0/11 (0%)

$14.72 (63.23%)

Buy

$44

$18.79 (74.53%)

$44

1 months 24 days ago
(19-Sep-2024)

0/9 (0%)

$21.5 (95.56%)

Buy

$27

$1.79 (7.10%)

$27

2 months 2 days ago
(10-Sep-2024)

1/12 (8.33%)

$8.25 (44.00%)

40

Buy

$28

$2.79 (11.07%)

$31

3 months ago
(12-Aug-2024)

0/6 (0%)

$12.71 (83.13%)

Buy

$42

$16.79 (66.60%)

$40

3 months 14 days ago
(29-Jul-2024)

0/8 (0%)

$24.71 (142.91%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is VRDN (Viridian Therapeutics) average time for price targets to be met?

On average it took 124.31 days on average for the stock forecasts to be realized with a an average price target met ratio 13.61

Which analyst has the current highest performing score on VRDN (Viridian Therapeutics) with a proven track record?

JASON BUTLER

Which analyst has the most public recommendations on VRDN (Viridian Therapeutics)?

Jason Butler works at JMP and has 5 price targets and 3 ratings on VRDN

Which analyst is the currently most bullish on VRDN (Viridian Therapeutics)?

Maneka Mirchandaney with highest potential upside - $29.79

Which analyst is the currently most reserved on VRDN (Viridian Therapeutics)?

Kalpit Patel with lowest potential downside - -$5.21

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?